Otsuka Pharmaceutical Expands Babi Mild to Target 50+ Market with New Line

Otsuka Pharmaceutical, a leading Thai consumer goods manufacturer, has announced the launch of a new product line, "Babi Mild & Beyond Immortelle," under its popular "Babi Mild" brand. This new product line aims to refresh the image of traditional baby care products and specifically target mature consumers aged 50 and above. This is positioned as part of the Babi Mild brand's cross-generational expansion strategy. Leveraging the trust and quality the Babi Mild brand has built over many years, Otsuka Pharmaceutical intends to develop products that meet the needs of consumers aged 50 and above, such as anti-aging and health-conscious options. The name "Immortelle" in the new product line is believed to be derived from the Immortelle flower, symbolizing longevity and regeneration, likely aiming to build anticipation for anti-aging benefits. This strategy is an effort to respond to demographic changes in Thailand, particularly the advancing aging population, and to capture new market opportunities. By expanding the brand image that Babi Mild has established in the baby care sector to a wider age range, Otsuka Pharmaceutical demonstrates its ambition for sustained business growth. Source: MGR Online (Business)